StockData
VolitionRx Ltd logo

VolitionRx Ltd (VNRX) stock

VNRXNYSEIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 4/30
$0.20−0.03 (-13.13%)

Close on Nov 16, 2026Market cap $2.73MP/E –Yield –

VolitionRx enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

VolitionRx's enterprise value was $5.33M on Nov 11, 2026, against $40.23M a year earlier. Over the last 5 years it ranged from $5.23M to $147.01M, with a median of $57.53M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$5.33M-83.8%
2025Dec 31, 2025$32.98M-38.6%
2024Dec 31, 2024$53.69M+11.5%
2023Dec 29, 2023$48.13M-62.0%
2022Dec 30, 2022$126.64M-13.9%
2021Dec 31, 2021$147.01M-12.8%
2020Dec 31, 2020$168.64M-4.9%
2019Dec 31, 2019$177.38M+260.2%
2018Dec 31, 2018$49.24M-24.9%
2017Dec 29, 2017$65.58M-31.2%
2016Dec 30, 2016$95.36M+27.9%
2015Dec 31, 2015$74.56M+39.7%
2014Dec 31, 2014$53.39M+95.6%
2013Dec 31, 2013$27.29M+1.3%
2012Dec 31, 2012$26.95M+151.2%
2011Dec 5, 2011$10.73M–

More VolitionRx figures

See a number that looks wrong?